自发性双胎贫血红细胞增多序列征:国际队列249例的诊断、管理与结局
该研究利用国际双胎贫血红细胞增多序列征登记库2014至2019年回顾性数据,纳入17个胎儿治疗中心共249例自发性病例,其中219例产前诊断、30例产后诊断。产前管理以激光手术最常见(39%),围产期死亡率为15%,供血儿22%高于受血儿7%(P<.001),严重新生儿病率为33%。
要点
- 自发性双胎贫血红细胞增多序列征可在妊娠14至35周之间发生,产前诊断中位孕周23.7周。
- 产前管理方式差异大,激光手术占39%,期待管理23%,分娩16%,宫内输血12%,选择性减胎8%,终止妊娠1%。
- 围产期死亡率供血儿22%高于受血儿7%(P<.001),严重新生儿病率两组相似(32% vs 33%,P=.628)。
核心结论
- 自发性双胎贫血红细胞增多序列征可在妊娠任何时间发生,从早孕期第二季度初至晚孕期第三季度末。
- 管理方式差异很大,激光手术是最常见的干预措施。
- 围产期死亡率和严重新生儿病率均较高,围产期死亡率在供血儿中尤其高。
研究设计与样本
- 国际双胎贫血红细胞增多序列征登记库的回顾性数据收集,收集时间为2014年至2019年。
- 共17个胎儿治疗中心参与数据收集,纳入249例自发性双胎贫血红细胞增多序列征病例。
- 主要结局为围产期死亡率和严重新生儿病率,次要结局包括围产期死亡率和严重新生儿病率的危险因素分析。
主要发现
- 249例中219例(88%)产前诊断,30例(12%)产后诊断;产前诊断的中位孕周为23.7周(四分位距9.7-28.8;范围15.1-35.3)。
- 产前管理:激光手术39%(86/219),期待管理23%(51/219),分娩16%(34/219),宫内输血(伴部分换血)12%(26/219),选择性减胎8%(18/219),终止妊娠1%(3/219)。
- 总体围产期死亡率为15%(72/493),供血儿为22%(54/243),受血儿为7%(18/242)(P<.001)。
- 严重新生儿病率发生于33%(141/432)的双胎贫血红细胞增多序列征双胎中,供血儿为32%(63/196),受血儿为33%(75/228)(P=.628)。
- 自发性围产期死亡的独立危险因素包括供血儿状态(比值比3.8;95%置信区间1.9-7.5;P<.001)、产前双胎贫血红细胞增多序列征分期(2期比值比6.3;95%置信区间1.4-27.8;P=.016;3期比值比9.6;95%置信区间2.1-45.5;P=.005;4期比值比20.9;95%置信区间3.0-146.4;P=.002)和出生孕周(比值比0.8;95%置信区间0.7-0.9;P=.001)。
关键数值与推荐
- 严重新生儿病率的独立危险因素包括产前双胎贫血红细胞增多序列征4期(比值比7.9;95%置信区间1.4-43.3;P=.018)和出生孕周(比值比1.7;95%置信区间1.5-2.1;P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Twin anemia polycythemia sequence is a chronic form of unbalanced fetofetal transfusion through minuscule placental anastomoses in monochorionic twins, leading to anemia in the donor and polycythemia in the recipient. Owing to the low incidence of twin anemia polycythemia sequence, data on diagnosis, management, and outcome are limited. OBJECTIVE: This study aimed to investigate the diagnosis, management, and outcome in a large international cohort of spontaneous twin anemia polycythemia sequence. STUDY DESIGN: Data from the international twin anemia polycythemia sequence registry, retrospectively collected between 2014 and 2019, were used for this study. A total of 17 fetal therapy centers contributed to the data collection. The primary outcomes were perinatal mortality and severe neonatal morbidity. Secondary outcomes included a risk factor analysis for perinatal mortality and severe neonatal morbidity. RESULTS: A total of 249 cases of spontaneous twin anemia polycythemia sequence were included in this study, 219 (88%) of which were diagnosed antenatally and 30 (12%) postnatally. Twin anemia polycythemia sequence was diagnosed antenatally at a median gestational age of 23.7 weeks (interquartile range, 9.7-28.8; range, 15.1-35.3). Antenatal management included laser surgery in 39% (86 of 219), expectant management in 23% (51 of 219), delivery in 16% (34 of 219), intrauterine transfusion (with partial exchange transfusion) in 12% (26 of 219), selective feticide in 8% (18 of 219), and termination of pregnancy in 1% (3 of 219) of cases. Perinatal mortality rate was 15% (72 of 493) for the total group, 22% (54 of 243) for donors, and 7% (18 of 242) for recipients (P<.001). Severe neonatal morbidity occurred in 33% (141 of 432) of twins with twin anemia polycythemia sequence and was similar for donors (32%; 63 of 196) and recipients (33%; 75 of 228) (P=.628). Independent risk factors for spontaneous perinatal mortality were donor status (odds ratio, 3.8; 95% confidence interval, 1.9-7.5; P<.001), antenatal twin anemia polycythemia sequence stage (odds ratio, 6.3; 95% confidence interval, 1.4-27.8; P=.016 [stage 2]; odds ratio, 9.6; 95% confidence interval, 2.1-45.5; P=.005 [stage 3]; odds ratio, 20.9; 95% confidence interval, 3.0-146.4; P=.002 [stage 4]), and gestational age at birth (odds ratio, 0.8; 95% confidence interval, 0.7-0.9; P=.001). Independent risk factors for severe neonatal morbidity were antenatal twin anemia polycythemia sequence stage 4 (odds ratio, 7.9; 95% confidence interval, 1.4-43.3; P=.018) and gestational age at birth (odds ratio, 1.7; 95% confidence interval, 1.5-2.1, P<.001). CONCLUSION: Spontaneous twin anemia polycythemia sequence can develop at any time in pregnancy from the beginning of the second trimester to the end of the third trimester. Management for twin anemia polycythemia sequence varies considerably, with laser surgery being the most frequent intervention. Perinatal mortality and severe neonatal morbidity were high, the former especially so in the donor twins.
引用
- Tollenaar LSA, Slaghekke F, Lewi L, et al. Spontaneous twin anemia polycythemia sequence: diagnosis, management, and outcome in an international cohort of 249 cases. Am J Obstet Gynecol. 2020. PMID: 32730900. doi:10.1016/j.ajog.2020.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。